Octagon Capital Advisors’s Fate Therapeutics FATE Stock Holding History

Octagon Capital Advisors’s Portfolio FATE Stock Details FATE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$1.71M	Hold
2024 Q1	$3.82M	Buy
2022 Q4	–	Sell
2022 Q3	$7.42M	Buy